Starbucks DOWNGRADED to Neutral and 4 Downgraded Shares Attracting Attention

July 27, 2012

Wall St. Watchdog reveals information about companies for which stock analysts downgraded the shares on July 27th.

Boston Scientific (NYSE:BSX): Northland Securities downgraded its rating on this company from Outperform to Market Perform and changed its price target from $7.5 to $5.5.

Don’t Miss: Samsung is OUTSELLING Apple.

Meridian Bioscience (NASDAQ:VIVO): Canaccord Genuity downgraded its rating on this company from Buy to Hold.

EMCOR Group (NYSE:EME): FBR Capital downgraded its rating on this company from Outperform to Mkt Perform and changed its price target from $33 to $26.

RadiSys (NASDAQ:RSYS): Needham downgraded its rating on this company from Buy to Hold.

Starbucks (NASDAQ:SBUX): Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target from $65 to $50.

Don’t Miss: Apple Catches a Break — For Now.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com